German F. Henostroza

German Henostroza practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

German Henostroza's NPI, 1578777827, was assigned on May 9, 2007. German Henostroza holds Alabama license 27271.

German Henostroza's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

German Henostroza's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. German Henostroza is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where German Henostroza practices. Vendor and product names are available with a free account.

Infectious disease is German Henostroza's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. German Henostroza is licensed in Alabama.

CMS data shows 261 Medicare services from German Henostroza across 4 procedure codes in 2024, for 129 Medicare patients. Medicare paid $18,714 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw German Henostroza in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts German Henostroza's median patient age at 65, with 53% women.

In 2024, German Henostroza wrote 508 Medicare Part D claims for 146 patients. 85% of them were for generic drugs. CMS names the drug for 273 of them, across 7 drugs with 11 or more claims each, at $12,382 in total drug cost. In 2023, CMS named 369 claims across 10 drugs.

German Henostroza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 26 papers to German Henostroza, published from 2011 to 2022. 2016 was the busiest year, with 4. The most frequent topics are Zambia, HIV Infections and Prisons. German Henostroza has published most often in Int J Tuberc Lung Dis. German Henostroza's most frequent co-authors are Gregory Paul Bisson, MD, Bryan S. Carter and Benjamin Chi, MD.

CMS Open Payments shows 2 general payments to German Henostroza from 2 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $125. It also lists 1 research payment totaling $139 in 2018.